Researchers uncover alarming number of undiagnosed hypertension, diabetes in heart study

September 28, 2001

DALLAS - Sept. 28, 2001 - A landmark heart disease study at UT Southwestern Medical Center, which will continue for at least seven more months, has already identified a large number of study participants who have undiagnosed high blood pressure or diabetes.

The Dallas Heart Disease Prevention Project, which began July 1, 2000, has interviewed more than 4,000 Dallas County participants out of the 6,000 that will be needed.

Of those, 1,186 cases of hypertension, or high blood pressure, were diagnosed, 417 of which were unaware of their condition. And 73 participants were unaware of their elevated glucose levels, indicating diabetes.

"It is essential to make people aware of these conditions, which are risk factors of cardiovascular disease," said Dr. Ronald Victor, scientific director of the project and chief of hypertension at UT Southwestern.

"This is the whole spirit behind this project. If it helps just one person it's worth it. So far, it's helped hundreds," Victor said. Confidential in-house interviews will be conducted through April 2002, and blood tests and clinical tests will continue throughout the summer of 2002.

To ensure successful results, researchers need residents who are selected to participate in the last two steps of the project, which is the first heart-disease prevention survey of a multiethnic population in a single metropolitan area.

The aim of the project is to reduce death and disability from coronary heart disease among Dallas County community members, who are affected by the disease at a higher rate than the national average.

Researchers will analyze the collected data to uncover new, treatable causes of heart disease and identify the barriers to awareness and treatment of heart disease in the various ethnic populations of Dallas.

Hypertension, which affects 50 million Americans, is often referred to as the silent killer because symptoms of high blood pressure are often unnoticeable until complications occur. Diabetes affects more than 16 million Americans, and was recently deemed an independent risk factor for coronary heart disease by the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults.

"High blood pressure and elevated blood glucose levels have a long asymptomatic phase in which the risk factors are producing damage to the cardiovascular system and setting that stage for a heart attack, stroke or kidney failure without making the person feel bad," Victor said.

"By the time things have gotten so bad and individuals are actually having symptoms of heart disease, the condition may have already reached the critical stage."

UT Southwestern was awarded a $24 million national competitive grant from the Donald W. Reynolds Foundation for cardiovascular clinical research in 1999. The award established the Donald W. Reynolds Cardiovascular Clinical Research Center. The Dallas Heart Disease Prevention Project is the centerpiece of the Reynolds Center that will bridge basic research and patient care.
-end-
The Donald W. Reynolds Foundation is a national philanthropic organization founded in 1954 by the late media entrepreneur for whom it is named.

For more information about the Dallas Heart Disease Prevention Project contact the hot line at 214-648-4555 or log onto the World Wide Web at http://cardiology.swmed.edu/heartbeat/.

This news release is available on our World Wide Web home page at http://www.utsouthwestern.edu/home_pages/news/

To automatically receive news releases from UT Southwestern via e-mail, send a message to UTSWNEWS-REQUEST@listserv.swmed.edu. Leave the subject line blank and in the text box, type SUB UTSWNEWS

UT Southwestern Medical Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.